The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmpyrean Regulatory News (EME)

Share Price Information for Empyrean (EME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.475
Bid: 0.40
Ask: 0.55
Change: 0.00 (0.00%)
Spread: 0.15 (37.50%)
Open: 0.475
High: 0.00
Low: 0.00
Prev. Close: 0.475
EME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Open Offer

11 May 2017 15:49

RNS Number : 9203E
Empyrean Energy PLC
11 May 2017
 

Empyrean Energy PLC

 

Result of Open Offer

 

On 24 April 2017, Empyrean Energy plc ("Empyrean" or the "Company") announced the launch of an Open Offer pursuant to which Qualifying Shareholders were able to subscribe for 1 new Ordinary Share in the Company at a price of 3.5 pence each for every 4 Ordinary Shares held at the Record Date.

 

The Open Offer closed for acceptance at 11.00 a.m. on 10 May 2017 and the Company is pleased to confirm that valid applications, including pursuant to the Excess Application Facility, were received in respect of a total of 34,316,551 new Ordinary Shares (the "Open Offer Shares"), being approximately 45.3 per cent. of the Ordinary Shares made available pursuant to the Open Offer. Accordingly, the Company has raised gross proceeds of approximately £1.2 million pursuant to the Open Offer.

 

Application has been made for the Open Offer Shares to be admitted to trading on AIM. Admission is expected to take place on 12 May 2017. These Open Offer Shares will rank pari passu with the existing Ordinary Shares.

 

Following the issue of the Open Offer Shares, Empyrean's total issued share capital will comprise 344,150,404 Ordinary Shares, each with voting rights. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, securities of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

The Company confirms that the directors of Empyrean subscribed for a total of 4,585,000 new Ordinary Shares at the Issue Price pursuant to the Open Offer, raising gross proceeds of approximately £0.16 million, representing 13% of the total proceeds raised pursuant to the Open Offer. Further details of the directors' holdings are set out in the table below:

 

Director

Previous Shareholding

Open Offer Shares applied for

Current Shareholding

% of Issued Share Capital

Thomas Kelly

38,881,563

2,000,000

40,881,563

11.88

Frank Brophy

2,223,333

1,800,000

4,023,333

1.17

John Laycock

1,200,000

500,000

1,700,000

0.49

Patrick Cross

340,000

285,000

625,000

0.18

 

As previously announced on 4 April 2017, the Company has entered into a sale and purchase agreement for the acquisition of up to a 20 per cent. interest in West Natuna Exploration Ltd from Conrad Petroleum Pte Ltd. Conrad is the registered and beneficial owner of WNEL, which holds a 100 per cent. participating interest in the highly prospective Duyung Production Sharing Contract in Indonesia.

 

Under the terms of the Acquisition, the Company has agreed to pay Conrad an initial cash consideration of US$2 million immediately upon signing of the shareholders' agreement (the "Shareholder Agreement") that is required to be negotiated and agreed between the Company and Conrad before completion of the Acquisition and, conditional on completion, the Company has agreed to pay a further US$2 million on or before 12 May 2017.

 

The Company is still in the process of negotiating the Shareholder Agreement with Conrad, and it is intended that the initial cash consideration of US$2 million will be paid from the Company's existing cash resources for an initial 10 per cent. shareholding in WNEL. As the gross proceeds of the Open Offer are not sufficient to allow the Company to pay the Further Consideration of US$2 million in respect of the additional 10 per cent. shareholding in WNEL, the Company is also seeking to agree an extension to the period for payment of this amount. In the event that such an extension is not agreed and / or the Company does not make payment of the Further Consideration, the Company's interest in WNEL will remain at 10 per cent.

 

As previously stated, the Board proposes to exercise its right, in circumstances where the Open Offer is not fully subscribed, to use its reasonable endeavours to place those Open Offer Shares not taken up, amounting to 43,141,912 Open Offer Shares, at not less than the Issue Price, in order to raise up to the maximum proceeds under the Open Offer.

 

Shareholders should note that there is no guarantee that an extension will be agreed with Conrad or that further funding will be available in order to allow the Company to satisfy the Further Consideration and acquire the additional 10 per cent. interest in WNEL.

 

Further announcements will be made in this regard in due course.

 

Tom Kelly, Empyrean CEO, commented:

 

"We are very pleased with the level of support for our Open Offer from our existing shareholders. We are confident of further support and hope to be in a position to update shareholders on both operational progress and the placing of remaining Open Offer shares in the very near future. It is very exciting times ahead for Empyrean as we embark on what the board believes are excellent exploration opportunities that have the leverage to transform the Company and provide excellent upside should our exploration be successful. We thank our shareholders for their continued support and particularly those who were able to participate in the Open Offer."

 

Terms and definitions used in this announcement have the meaning ascribed to them in the Circular dated 24 April 2017, unless the context requires otherwise.

 

Empyrean Energy plc

Tom Kelly

Tel: +61 8 9481 0389

Cenkos Securities plc

Neil McDonald

Tel: +44 (0) 131 220 9771

Beth McKiernan

Tel: +44 (0) 131 220 9778

Nick Tulloch

Tel: +44 (0) 131 220 9772

St Brides Partners Ltd

Elisabeth Cowell

Tel: +44 (0) 20 7236 1177

Lottie Brocklehurst

Tel: +44 (0) 20 7236 1177

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROIEALSFFLKXEFF
Date   Source Headline
5th Apr 20247:00 amRNSDirector/PDMR Shareholding
28th Mar 20247:57 amRNSMako Gas Sale Key Terms Signed with PGN
23rd Feb 20247:39 amRNSMinisterial Approval of Mako Gas Price
13th Feb 20247:00 amRNSEmpyrean completes £700,000 Placing
31st Jan 20247:00 amRNSDuyung PSC Update
18th Dec 202311:34 amRNSInterim Results
20th Nov 20232:40 pmRNSChange of Nominated Adviser
27th Sep 202312:58 pmRNSResult of AGM
15th Sep 20237:00 amRNSIssue of Salary Sacrifice Shares
12th Sep 20237:13 amRNSKey Terms Agreed for Long-Term Gas Sales Agreement
4th Sep 20237:00 amRNSPosting of Annual Report and Notice of AGM
1st Sep 202312:30 pmRNSFinal Results
30th May 20237:36 amRNSCapital raising, Debt Restructure & Company Update
2nd May 20237:00 amRNSMako gas field - Update
4th Jan 20234:40 pmRNSSecond Price Monitoring Extn
4th Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20234:35 pmRNSPrice Monitoring Extension
20th Dec 20227:00 amRNSInterim Results
23rd Nov 20224:36 pmRNSPrice Monitoring Extension
8th Nov 20227:00 amRNSMako Gas - Approval of Updated Plan of Development
19th Oct 20221:19 pmRNSResults of General Meeting
27th Sep 202212:54 pmRNSResult of AGM
26th Sep 202212:01 pmRNSPosting of Annual Report and Notice of GM
16th Sep 20227:08 amRNSFinal Results
9th Sep 20227:00 amRNSMako Gas Project - Updated Plan of Development
2nd Sep 20229:04 amRNSPosting of Notice of Annual General Meeting
10th Jun 20227:00 amRNSSecond phase of exploration for Topaz Prospect
7th Jun 20227:00 amRNSChange of Registered Office Address
23rd May 20228:40 amRNSHolding(s) in Company
12th May 20224:41 pmRNSSecond Price Monitoring Extn
12th May 20224:36 pmRNSPrice Monitoring Extension
10th May 202211:45 amRNSCapital raising, drill analysis & debt restructure
4th May 20227:33 amRNSProposed drilling of Topaz Prospect
27th Apr 20227:00 amRNSJade well reached Total Depth
25th Apr 202211:59 amRNSHolding(s) in Company
21st Apr 20228:37 amRNSExercise of Warrants
19th Apr 20227:00 amRNSBlock 29/11, China - Jade drilling update
13th Apr 20227:43 amRNSDrilling update at Jade prospect
11th Apr 202212:32 pmRNSExercise of Warrants
11th Apr 20227:00 amRNSDrilling commences at Jade prospect
8th Apr 20229:55 amRNSExercise of Warrants
8th Apr 20227:00 amRNSBlock 29/11, China - NH9 rig on Jade location
4th Apr 20227:00 amRNSBlock 29/11, China – NH9 rig to mobilise
30th Mar 20228:16 amRNSBlock 29/11, China - Jade well update
28th Mar 20228:01 amRNSPartial Conversion of Convertible Note
25th Mar 20227:34 amRNSRig Mobilisation and Anticipated Spud Date
16th Mar 20229:52 amRNSPartial Conversion of Convertible Note
11th Mar 20227:42 amRNSBlock 29/11, China – Jade drilling update
10th Mar 20227:00 amRNSEmpyrean moves to SETS trading platform

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.